Literature DB >> 23011021

[New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].

I Esposito1, B Konukiewitz, A M Schlitter, G Klöppel.   

Abstract

The identification and characterization of precursor lesions is fundamental to develop screening programs for early diagnosis and treatment, aiming at reducing cancer-related mortality. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease that becomes clinical apparent only in advanced stages. In order to enable screening procedures for early detection of PDAC, an exact characterization of precursor lesions is of utmost importance. Pancreatic intraepithelial neoplasias (PanIN) are the most frequent and best characterized precursors of PDAC and are lesions with a ductal phenotype thus indicating a ductal cell origin of PDAC. However, evidence from genetically engineered mouse models suggests that tubular complexes (TC) originating through a process of acinar-ductal metaplasia (ADM) form atypical flat lesions (AFL) that may represent an alternative pathway of pancreatic carcinogenesis. Based on a thorough morphological and genetic analysis of murine TC, AFL and PanIN and their human counterparts, a new dual model of pancreatic carcinogenesis is proposed taking into account the role of AFL as possible new precursors of PDAC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011021     DOI: 10.1007/s00292-012-1673-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  33 in total

1.  Osteoclast-like giant cell tumor of the pancreas associated with a mucinous cystadenocarcinoma.

Authors:  Amod A Sarnaik; Aly G Saad; George K Mutema; Stephen P Martin; Ahmad Attar; Andrew M Lowy
Journal:  Surgery       Date:  2003-06       Impact factor: 3.982

2.  Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Authors:  Michaela Aichler; Christopher Seiler; Monica Tost; Jens Siveke; Pawel K Mazur; Patricia Da Silva-Buttkus; Detlef K Bartsch; Peter Langer; Sara Chiblak; Anna Dürr; Heinz Höfler; Günter Klöppel; Karin Müller-Decker; Markus Brielmeier; Irene Esposito
Journal:  J Pathol       Date:  2012-01-17       Impact factor: 7.996

3.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

4.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

Review 5.  Pancreatic intraepithelial neoplasia revisited and updated.

Authors:  B Sipos; S Frank; T Gress; S Hahn; G Klöppel
Journal:  Pancreatology       Date:  2008-12-12       Impact factor: 3.996

6.  Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.

Authors:  Irene Esposito; Christopher Seiler; Frank Bergmann; Jörg Kleeff; Helmut Friess; Peter Schirmacher
Journal:  Pancreas       Date:  2007-10       Impact factor: 3.327

7.  Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.

Authors:  Jonathan E Lim; Michael W Chien; Craig C Earle
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

8.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Authors:  John P Morris; David A Cano; Shigeki Sekine; Sam C Wang; Matthias Hebrok
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

Review 9.  Maximizing mouse cancer models.

Authors:  Kristopher K Frese; David A Tuveson
Journal:  Nat Rev Cancer       Date:  2007-09       Impact factor: 60.716

10.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

Authors:  Carmen Guerra; Alberto J Schuhmacher; Marta Cañamero; Paul J Grippo; Lena Verdaguer; Lucía Pérez-Gallego; Pierre Dubus; Eric P Sandgren; Mariano Barbacid
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

View more
  7 in total

Review 1.  Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Authors:  Irene Esposito; Björn Konukiewitz; Anna Melissa Schlitter; Günter Klöppel
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

2.  Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Ole Helm; Ruben Mennrich; Domantas Petrick; Lisa Goebel; Sandra Freitag-Wolf; Christian Röder; Holger Kalthoff; Christoph Röcken; Bence Sipos; Dieter Kabelitz; Heiner Schäfer; Hans-Heinrich Oberg; Daniela Wesch; Susanne Sebens
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

3.  The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.

Authors:  Geeske Genrich; Marcus Kruppa; Lennart Lenk; Ole Helm; Anna Broich; Sandra Freitag-Wolf; Christoph Röcken; Bence Sipos; Heiner Schäfer; Susanne Sebens
Journal:  BMC Cancer       Date:  2016-02-25       Impact factor: 4.430

4.  Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models.

Authors:  Claudio Ricci; Carlos Mota; Stefania Moscato; Delfo D'Alessandro; Stefano Ugel; Silvia Sartoris; Vincenzo Bronte; Ugo Boggi; Daniela Campani; Niccola Funel; Lorenzo Moroni; Serena Danti
Journal:  Biomatter       Date:  2014

Review 5.  Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma.

Authors:  Albrecht Neesse; Sebastian Krug; Thomas M Gress; David A Tuveson; Patrick Michl
Journal:  Onco Targets Ther       Date:  2013-12-18       Impact factor: 4.147

6.  Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice.

Authors:  Marta Cáceres; Rita Quesada; Mar Iglesias; Francisco X Real; Maria Villamonte; Jaime Martinez de Villarreal; Mónica Pérez; Ana Andaluz; Xavier Moll; Enrique Berjano; Dimitri Dorcaratto; Patricia Sánchez-Velázquez; Luís Grande; Fernando Burdío
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

Review 7.  Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia.

Authors:  Friederike V Opitz; Lena Haeberle; Alexandra Daum; Irene Esposito
Journal:  Cancers (Basel)       Date:  2021-12-08       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.